Avandia Recall

Release of Senate Committee on Finance Report Prompt FDA Claims for Recall of Avandia, Drug Prescribed to Treat Type 2 Diabetes

A February 2010 press release issued by senior members of Senate Committee on Finance regarding FDA and pharmaceutical company oversight of Avandia lead to calls for a recall of the drug. The study cites research showing a link between the use of Avandia and an increased risk for heart attacks or other serious cardiac complications.

If your family is facing a loved one’s diagnosis with a heart attack, heart failure or other serious cardiac injury after taking Avandia to treat their Type 2 diabetes, please complete the form on this page for more information from our attorneys about your legal rights.

The release of the findings from a two-year study and investigation conducted by the U.S. Congress Department of Finance about Avandia has led to intense speculation that the U.S. Food and Drug Administration (FDA) may now issue a recall of the diabetes drug.

As of February 22, 2010, a number of reputable print, television and TV news sources have cited confidential FDA sources stating that the FDA may ask GlaxoSmithKline (Glaxo), the company that markets the diabetes drug, to issue a voluntary recall.

2007 Study
At issue is a 2007 study published in the New England Journal of Medicine which evaluated Type 2 diabetes patients who were taking Avandia. The study results showed that Avandia patients had a 43 percent higher risk to have a heart attack or suffer other serious cardiac events than patients being treated with other drugs.

Later in 2007, the company revised their patient labeling information to advise that Avandia could cause or increase the chances that patients could develop congestive heart failure.

Finance Committee Report
In January 2010, the Congressional Finance Committee issued a 342 page report about the drug and the company’s actions in light of the Journal of Medicine study. In particular, the report discusses whether Glaxo had been forthcoming with regard to the number of Avandia patients who subsequently suffered a heart attack or other serious heart problem while taking the drug, and whether the company had provided that information to the FDA, physicians and patients in a timely manner.

Get Help from Weitz & Luxenberg
If you or a loved one has suffered a heart attack or other serious cardiac complications after taking Avandia to treat their diabetes, our lawyers may be able to help you seek compensation against the responsible companies for the injury, pain and suffering, and other monetary compensation to defray medical or other expenses.

Please complete the form on this page for a free review of your potential lawsuit. A Weitz & Luxenberg representative will contact you as soon as possible.

Click To Talk To Us Online

June 2010 News

Avandia drug news about serious health risks | Weitz & Luxenberg
Avandia news, info and free lawsuit review is available for diabetes patients who suffered heart problems after taking the drug to treat Type 2 diabetes.

NEJM Study

Avandia Drug NEJM Study | Weitz & Luxenberg
Study on Rosiglitazone (Avandia) Medication and Risk of Cardiac Issues

News & Warnings

Avandia News and Information | Weitz & Luxenberg
Bloomberg News: FDA Warned Glaxo about Avandia Marketing in 2001

Name

Phone

strictly confidential

Your Question

Contact Name
Email Address
Phone Number
When did you start taking Avandia?
Did you experience cardiovascular problems after taking Avandia?
What was the date you experienced cardiac complications?
Did you have any cardiovascular disease before taking Avandia?
Did you suffer a bone fracture after taking either Avandia or Actos?
Please provide detail about your bone fracture injury, including the date of the injury, how the fracture occured and what bone(s) were affected.
Additional information